Frequency of Pulmonary Toxicity in Patients Treated for Hodgkin Lymphoma

Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs

NCT05284396 ·Status: UNKNOWN

Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy

NCT00165438 ·Status: COMPLETED

Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)

NCT06170216 ·Status: ACTIVE_NOT_RECRUITING

A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).

NCT00301314 ·Status: COMPLETED

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices

NCT02856646 ·Status: COMPLETED

Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma

NCT03664323 ·Status: COMPLETED

Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma

NCT03602131 ·Status: UNKNOWN ·Phase: PHASE2

Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

NCT01820117 ·Status: COMPLETED

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

NCT05977673 ·Status: RECRUITING ·Phase: PHASE2

Prognostic Value Of Lymphocyte Count and Lymphocyte/ Monocyte Ratio in Patients With Hodgkin's Lymphoma

NCT04893538 ·Status: UNKNOWN

Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors

NCT00001301 ·Status: COMPLETED

Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma

NCT05772624 ·Status: UNKNOWN ·Phase: PHASE2

A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)

NCT01573000 ·Status: COMPLETED ·Phase: PHASE2

Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma

NCT05179213 ·Status: UNKNOWN ·Phase: PHASE2

Radiation Free Chemotherapy for Early Hodgkin Lymphoma

NCT04866654 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.

NCT04621604 ·Status: TERMINATED ·Phase: NA

Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy

NCT02404818 ·Status: COMPLETED

Relationship Between Serum β2-Microglobulin and Infiltration of CD8+ in the Tumor Tissue of Hodgkin's Lymphoma Patients

NCT06564259 ·Status: COMPLETED

Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma

NCT00143871 ·Status: COMPLETED ·Phase: PHASE2

A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers

NCT00262210 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab

NCT01461928 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

NCT06170489 ·Status: RECRUITING ·Phase: PHASE3

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

NCT05705531 ·Status: RECRUITING

Gonadal Toxicity in Women With Hodgkin Lymphoma

NCT01008735 ·Status: UNKNOWN

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab

NCT00240591 ·Status: COMPLETED